McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia—an overview. JAMA Psychiatry. 2020;77:201–10.
Google Scholar
Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399:473–86.
Google Scholar
Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, et al. Schizophrenia. Nat Rev Disease Primers. 2015;1:15067.
Google Scholar
Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388:86–97.
Google Scholar
Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull. 2009;35:528–48.
Google Scholar
Khavari B, Cairns MJ. Epigenomic dysregulation in schizophrenia: in search of disease etiology and biomarkers. Cells. 2020;9:1837.
Kuehner JN, Bruggeman EC, Wen Z, Yao B. Epigenetic regulations in neuropsychiatric disorders. Front Genet. 2019;10:268.
Google Scholar
Tochigi M, Iwamoto K, Bundo M, Komori A, Sasaki T, Kato N, et al. Methylation status of the reelin promoter region in the brain of schizophrenic patients. Biological psychiatry. 2008;63:530–3.
Google Scholar
Nabil Fikri RM, Norlelawati AT, Nour El-Huda AR, Hanisah MN, Kartini A, Norsidah K, et al. Reelin (RELN) DNA methylation in the peripheral blood of schizophrenia. J Psychiatric Res. 2017;88:28–37.
Google Scholar
Abdolmaleky HM, Cheng K-h, Faraone SV, Wilcox M, Glatt SJ, Gao F, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Human Mol Genet. 2006;15:3132–45.
Google Scholar
Nohesara S, Ghadirivasfi M, Mostafavi S, Eskandari M-R, Ahmadkhaniha H, Thiagalingam S, et al. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatric Res. 2011;45:1432–8.
Google Scholar
Cheah S-Y, Lawford BR, Young RM, Morris CP, Voisey J. mRNA expression and DNA methylation analysis of serotonin receptor 2A (HTR2A) in the human schizophrenic brain. Genes. 2017;82017:14.
Carrard A, Salzmann A, Malafosse A, Karege F. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J Affective Disorders. 2011;132:450–3.
Google Scholar
Ikegame T, Bundo M, Sunaga F, Asai T, Nishimura F, Yoshikawa A, et al. DNA methylation analysis of BDNF gene promoters in peripheral blood cells of schizophrenia patients. Neurosci Res. 2013;77:208–14.
Google Scholar
Kordi-Tamandani DM, Sahranavard R, Torkamanzehi A. DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia. Mol Biol Rep. 2012;39:10889–93.
Google Scholar
Cheah S-Y, McLeay R, Wockner LF, Lawford BR, Young RM, Morris CP, et al. Expression and methylation of BDNF in the human brain in schizophrenia. World J Biol Psychiatry. 2017;18:392–400.
Google Scholar
Pickard BS. Schizophrenia biomarkers: translating the descriptive into the diagnostic. J Psychopharmacol. 2015;29:138–43.
Google Scholar
Weickert CS, Weickert TW, Pillai A, Buckley PF. Biomarkers in schizophrenia: a brief conceptual consideration. Dis Markers. 2013;35:3–9.
Google Scholar
Lozupone M, La Montagna M, D’Urso F, Daniele A, Greco A, Seripa D, et al. The role of biomarkers in psychiatry. Adv Exp Med Biol. 2019;1118:135–62.
Google Scholar
Guidotti A, Auta J, Davis JM, Dong E, Gavin DP, Grayson DR, et al. Toward the identification of peripheral epigenetic biomarkers of schizophrenia. J Neurogenet. 2014;28:41–52.
Google Scholar
Guncar G, Kukar M, Notar M, Brvar M, Cernelc P, Notar M, et al. An application of machine learning to haematological diagnosis. Sci Rep. 2018;8:411.
Google Scholar
Abdar M, Ksiazek W, Acharya UR, Tan RS, Makarenkov V, Plawiak P. A new machine learning technique for an accurate diagnosis of coronary artery disease. Comput Methods Programs Biomed. 2019;179:104992.
Google Scholar
Elaziz MA, Hosny KM, Salah A, Darwish MM, Lu S, Sahlol AT. New machine learning method for image-based diagnosis of COVID-19. PLoS ONE. 2020;15:e0235187.
Google Scholar
Tsamardinos I, Charonyktakis P, Papoutsoglou G, Borboudakis G, Lakiotaki K, Zenklusen JC, et al. Just Add Data: automated predictive modeling for knowledge discovery and feature selection. NPJ Precis Oncol. 2022;6:38.
Google Scholar
Tsamardinos I, Greasidou E, Borboudakis G. Bootstrapping the out-of-sample predictions for efficient and accurate cross-validation. Mach Learn. 2018;107:1895–922.
Google Scholar
Paparazzo E, Geracitano S, Lagani V, Bartolomeo D, Aceto MA, D’Aquila P, et al. A blood-based molecular clock for biological age estimation. Cells. 2022;12:32.
Jacob SG, Sulaiman MMBA, Bennet B. Feature signature discovery for autism detection: an automated machine learning based feature ranking framework. Comput Intell Neurosci. 2023;2023:6330002.
Google Scholar
Deutsch L, Stres B. The importance of objective stool classification in fecal 1H-NMR metabolomics: exponential increase in stool crosslinking is mirrored in systemic inflammation and associated to fecal acetate and methionine. Metabolites. 2021;11:172.
Danilatou V, Nikolakakis S, Antonakaki D, Tzagkarakis C, Mavroidis D, Kostoulas T, et al. Outcome prediction in critically-Ill patients with venous thromboembolism and/or cancer using machine learning algorithms: external validation and comparison with scoring systems. Int J Mol Sci. 2022;23:7132.
Rounis K, Makrakis D, Papadaki C, Monastirioti A, Vamvakas L, Kalbakis K, et al. Correction: prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study. PLoS ONE. 2023;18:e0294382.
Google Scholar
Bowler S, Papoutsoglou G, Karanikas A, Tsamardinos I, Corley MJ, Ndhlovu LC. A machine learning approach utilizing DNA methylation as an accurate classifier of COVID-19 disease severity. Sci Rep. 2022;12:17480.
Google Scholar
Papoutsoglou G, Karaglani M, Lagani V, Thomson N, Roe OD, Tsamardinos I, et al. Automated machine learning optimizes and accelerates predictive modeling from COVID-19 high throughput datasets. Sci Rep. 2021;11:15107.
Google Scholar
Karaglani M, Panagopoulou M, Baltsavia I, Apalaki P, Theodosiou T, Iliopoulos I, et al. Tissue-specific methylation biosignatures for monitoring diseases: an in silico approach. Int J Mol Sci. 2022;23:2959.
Karaglani M, Gourlia K, Tsamardinos I, Chatzaki E. Accurate blood-based diagnostic biosignatures for alzheimer’s disease via automated machine learning. J Clin Med. 2020;9:3016.
Panagopoulou M, Karaglani M, Manolopoulos VG, Iliopoulos I, Tsamardinos I, Chatzaki E. Deciphering the methylation landscape in breast cancer: diagnostic and prognostic biosignatures through automated machine learning. Cancers (Basel). 2021;13:1677.
Adamou M, Antoniou G, Greasidou E, Lagani V, Charonyktakis P, Tsamardinos I, et al. Toward automatic risk assessment to support suicide prevention. Crisis. 2019;40:249–56.
Google Scholar
Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res. 2012;41:D991–D995.
Google Scholar
Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K, et al. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol. 2012;13:R97.
Google Scholar
Piao YH, Cui Y, Rami FZ, Li L, Karamikheirabad M, Kang SH, et al. Methylome-wide association study of patients with recent-onset psychosis. Clin Psychopharmacol Neurosci. 2022;20:462–73.
Google Scholar
Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr Protocols Bioinform. 2016;54:1.30.1–1.30.33.
Google Scholar
Boutet E, Lieberherr D, Tognolli M, Schneider M, Bairoch A. UniProtKB/Swiss-Prot. Methods Mol Biol (Clifton, NJ). 2007;406:89–112.
Theodosiou T, Papanikolaou N, Savvaki M, Bonetto G, Maxouri S, Fakoureli E, et al. UniProt-Related Documents (UniReD): assisting wet lab biologists in their quest on finding novel counterparts in a protein network. NAR Genom Bioinform. 2020;2:lqaa005.
Google Scholar
Baltsavia I, Theodosiou T, Papanikolaou N, Pavlopoulos GA, Amoutzias GD, Panagopoulou M, et al. Prediction and ranking of biomarkers using multiple UniReD. Int J Mol Sci. 2022;23:11112.
Savvaki M, Kafetzis G, Kaplanis SI, Ktena N, Theodorakis K, Karagogeos D. Neuronal, but not glial, Contactin 2 negatively regulates axon regeneration in the injured adult optic nerve. Eur J Neurosci. 2021;53:1705–21.
Google Scholar
Kalafatakis I, Kalafatakis K, Tsimpolis A, Giannakeas N, Tsipouras M, Tzallas A, et al. Using the Allen gene expression atlas of the adult mouse brain to gain further insight into the physiological significance of TAG-1/Contactin-2. Brain Struct Funct. 2020;225:2045–56.
Google Scholar
Antuamwine BB, Bosnjakovic R, Hofmann-Vega F, Wang X, Theodosiou T, Iliopoulos I, et al. N1 versus N2 and PMN-MDSC: a critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol Rev. 2023;314:250–79.
Google Scholar
Boulenouar H, Benhatchi H, Guermoudi F, Oumiloud AH, Rahoui A. An actualized screening of schizophrenia-associated genes. Egyptian J Med Human Genet. 2022;23:81.
Google Scholar
Zhan N, Sham PC, So H-C, Lui SSY. The genetic basis of onset age in schizophrenia: evidence and models. Front Genet. 2023;14:1163361.
Johansson AS, Owe-Larsson B, Hetta J, Lundkvist GB. Altered circadian clock gene expression in patients with schizophrenia. Schizophrenia Res. 2016;174:17–23.
Google Scholar
Meltzer HY, Li Z, Huang M, Prus A. Serotonergic mechanisms in schizophrenia: evolution and current concepts. Curr Psychosis Therapeutics Reports. 2006;4:12–9.
Google Scholar
Wagh VV, Vyas P, Agrawal S, Pachpor TA, Paralikar V, Khare SP. Peripheral blood-based gene expression studies in schizophrenia: a systematic review. Front Genet. 2021;12:736483.
Google Scholar
Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605–D612.
Google Scholar
Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics (Oxford, England). 2002;18:1427–31.
Google Scholar
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif). 2001;25:402–8.
Google Scholar
Ravanidis S, Kattan FG, Doxakis E. Unraveling the pathways to neuronal homeostasis and disease: mechanistic insights into the role of RNA-binding proteins and associated factors. Int J Mol Sci. 2018;19:2280.
Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999;19:1262–70.
Google Scholar
Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285–95.
Google Scholar
Zhang Y, You X, Li S, Long Q, Zhu Y, Teng Z, et al. Peripheral blood leukocyte RNA-seq identifies a set of genes related to abnormal psychomotor behavior characteristics in patients with schizophrenia. Med Sci Monitor: Int Med J Exp Clin Res. 2020;26:e922426.
Google Scholar
Glatt SJ, Stone WS, Nossova N, Liew CC, Seidman LJ, Tsuang MT. Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. Am J Med Genet B: Neuropsychiatric Genet. 2011;156B:869–87.
Google Scholar
Chan MK, Krebs MO, Cox D, Guest PC, Yolken RH, Rahmoune H, et al. Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset. Transl Psychiatry. 2015;5:e601.
Google Scholar
Lin E, Lin CH, Lai YL, Huang CH, Huang YJ, Lane HY. Combination of G72 genetic variation and G72 protein level to detect schizophrenia: machine learning approaches. Front Psychiatry. 2018;9:566.
Google Scholar
Trakadis YJ, Sardaar S, Chen A, Fulginiti V, Krishnan A. Machine learning in schizophrenia genomics, a case-control study using 5,090 exomes. Am J Med Genet B: Neuropsychiatric Genet. 2019;180:103–12.
Google Scholar
Chen J, Zang Z, Braun U, Schwarz K, Harneit A, Kremer T, et al. Association of a reproducible epigenetic risk profile for schizophrenia with brain methylation and function. JAMA Psychiatry. 2020;77:628–36.
Google Scholar
Ke PF, Xiong DS, Li JH, Pan ZL, Zhou J, Li SJ, et al. An integrated machine learning framework for a discriminative analysis of schizophrenia using multi-biological data. Sci Rep. 2021;11:14636.
Google Scholar
Zhu L, Wu X, Xu B, Zhao Z, Yang J, Long J, et al. The machine learning algorithm for the diagnosis of schizophrenia on the basis of gene expression in peripheral blood. Neurosci Lett. 2021;745:135596.
Google Scholar
Gunasekara CJ, Hannon E, MacKay H, Coarfa C, McQuillin A, Clair DS, et al. A machine learning case–control classifier for schizophrenia based on DNA methylation in blood. Transl Psychiatry. 2021;11:412.
Google Scholar
Lu AK, Lin JJ, Tseng HH, Wang XY, Jang FL, Chen PS, et al. DNA methylation signature aberration as potential biomarkers in treatment-resistant schizophrenia: Constructing a methylation risk score using a machine learning method. J Psychiatric Res. 2023;157:57–65.
Google Scholar
Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, et al. Altering the course of schizophrenia: progress and perspectives. Nat Rev Drug Discov. 2016;15:485–515.
Google Scholar
Hannon E, Dempster E, Viana J, Burrage J, Smith AR, Macdonald R, et al. An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation. Genome Biol. 2016;17:176.
Google Scholar
Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J psychiatry. 2002;159:1080–92.
Google Scholar
Sarris J, Logan AC, Akbaraly TN, Amminger GP, Balanzá-Martínez V, Freeman MP, et al. Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry. 2015;2:271–4.
Google Scholar
Arias I, Sorlozano A, Villegas E, de Dios Luna J, McKenney K, Cervilla J, et al. Infectious agents associated with schizophrenia: a meta-analysis. Schizophrenia Res. 2012;136:128–36.
Google Scholar
Vassos E, Pedersen CB, Murray RM, Collier DA, Lewis CM. Meta-analysis of the association of urbanicity with schizophrenia. Schizophrenia Bull. 2012;38:1118–23.
Google Scholar
Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry : the journal of mental science. 2004;184:110–7.
Google Scholar
Liang H, Olsen J, Yuan W, Cnattingus S, Vestergaard M, Obel C, et al. Early life bereavement and schizophrenia: a nationwide cohort study in Denmark and Sweden. Medicine (Baltimore). 2016;95:e2434.
Google Scholar
Gao Z, Li B, Guo X, Bai W, Kou C. The association between schizophrenia and white blood cells count: a bidirectional two-sample Mendelian randomization study. BMC Psychiatry. 2023;23:271.
Google Scholar
Yazgili AS, Ebstein F, Meiners S. The proteasome activator PA200/PSME4: an emerging new player in health and disease. Biomolecules 2022;12:1150.
Smeland OB, Bahrami S, Frei O, Shadrin A, O’Connell K, Savage J, et al. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence. Mol Psychiatry. 2020;25:844–53.
Google Scholar
Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984–94.
Google Scholar
